Daiho anti-cancer drug jointly to conduct clinical phase II studies in Korea.
McChem Health and Yonsei University Cancer Center jointly reported on Oct. 23 that a phase II local clinical study for TSU 68, an anti-cancer drug developed by Daiho J...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
